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Abstract
Background and aims: Persistent tendinopathies were pre-
viously considered solely as peripheral conditions affect-
ing the local tendinous tissue until quantitative sensory 
testing identified involvement of altered pain processing. 
In similar fashion, pain in patients with persistent plantar 
fasciopathy may also involve more than local tissue. The 
aim of this pilot study was to investigate potential differ-
ences in conditioned pain modulation and pressure and 
thermal pain thresholds, between individuals with PF and 
healthy pain-free controls, as a precursor to a larger-scale 
study.
Methods: We assessed 16 individuals with plantar fascio-
pathy and 11 pain-free controls. Plantar fasciopathy diag-
nosis was: palpation pain of the medial calcaneal tubercle 
or the proximal plantar fascia, duration ≥3 months, pain 
intensity ≥2/10, and ultrasound-measured plantar fascia 
thickness ≥4  mm. Quantitative sensory tests were per-
formed locally at the plantar heel and remotely on the ipsi-
lateral elbow. Assessments included pain thresholds for 
pressure, heat and cold, and conditioned pain modulation 
measured as change in local resting pressure pain thresh-
old with cold water hand immersion. Participants rated 
pain intensity at pain threshold. Additionally, the area and 
distribution of plantar fasciopathy pain was drawn on a 
digital body chart of the lower limbs. Descriptive analyses 
were performed and between-group differences/effects 
expressed as standardised mean differences (d).
Results: There was no conditioned pain modulation dif-
ference between participants with plantar fasciopathy and 
controls (d = 0.1). Largest effects were on local pressure pain 
threshold and reported pain intensity on pressure pain 
threshold (d > 1.8) followed by pain intensity for heat and 
cold pain thresholds (d = 0.3–1.5). According to the digital 
body chart, pain area extended beyond the plantar heel.
Conclusions: The unlikelihood of a difference in condi-
tioned pain modulation yet a pain area extending beyond 
the plantar heel provide a basis for exploring altered pain 
processing in a larger-scale study.
Implications: This was the first study to investigate the 
presence of altered pain processing in individuals with 
plantar fasciopathy using a conditioned pain modulation 
paradigm and thermal pain thresholds. We found no indi-
cation of an altered pain processing based on these meas-
ures, however, patients rated pain higher on thresholds 
compared to controls which may be important to clinical 
practice and warrants further exploration in the future.
Keywords: plantar fasciopathy; conditioned pain modu-
lation; pressure pain threshold; thermal pain threshold; 
pain distribution; pain experience on pain threshold.
1   Introduction
Plantar fasciopathy (formerly known as plantar fasciitis) is 
one of the most common musculoskeletal conditions with 
a lifetime prevalence of 10% and has the second highest 
prevalence and incidence rate among lower extremity ten-
dinopathies [1–4]. The condition is characterised by severe 
and sharp heel pain. Patients often report pain during their 
first steps in the morning or after inactivity which improves 
with ambulation and worsens during the day [5].
Historically, tendinopathies have been considered 
peripheral conditions only involving the tendons. Recent evi-
dence challenges this notion and suggests that altered pain 
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processing may contribute to persistent pain in tendinopa-
thy which is similar to findings in other chronic pain condi-
tions [6–12]. Three recent studies comparing individuals with 
plantar fasciopathy and healthy controls found conflicting 
evidence; two studies found local and widespread mechani-
cal hyperalgesia whereas one did not find any differences [13–
15]. These inconsistent reports prompt further investigation 
of pain processing, especially as all three studies assessed 
mechanical hyperalgesia using pressure pain thresholds 
(PPT). PPT assessment is only one of many quantitative 
sensory testing (QST) approaches that provide information 
about somatosensory function as different tests assess differ-
ent primary afferent fibres [16, 17]. For example, additional 
gains in information about somatosensory function and 
pain processing can be achieved using thermal pain thresh-
olds and conditioned pain modulation (CPM) tests. PPT tests 
and cold pain involve the A∂ and C fibers whereas heat pain 
is believed to primarily access C fibers with less involvement 
of A∂ fibers [16, 17]. CPM tests assess differences in PPT from 
before to during or after a remote painful stimulus and if PPT is 
not increased during or after the painful stimulus, the endog-
enous pain inhibition has been affected negatively [18]. These 
additional QST tests will likely provide further clarity on any 
altered pain processing in plantar fasciopathy and may even 
direct future treatment options as CPM has been found to be 
associated with the effect of pharmacological interventions 
in neuropathy [16]. In addition to QSTs, asking patients to 
draw their pain on body charts may provide further insight 
into the pain features of a chronic condition [19]. Persistent 
musculoskeletal conditions tend to occur with spreading area 
of pain, but digital pain drawings by patients with bilateral 
patellofemoral pain have revealed that pain may also present 
in symmetrical pain patterns which suggests the involvement 
of central neuronal mechanisms [19, 20]. Whether this is also 
a feature of PF remains unknown.
The aim of this pilot study was to explore thermal 
pain thresholds and conditioned pain modulation, in 
addition to pressure pain thresholds, in individuals with 
plantar fasciopathy compared with healthy pain-free con-
trols and to explore pain area and distribution. This pilot 
study was conducted to inform planning of a larger-scale 
hypothesis-testing study.
2   Methods
2.1   Study design
This study was designed as a cross-sectional pilot study 
in which a single assessor conducted QSTs of cold, heat 
and pressure pain thresholds in individuals with plantar 
fasciopathy (PF group) and healthy pain-free individu-
als (control group). In order to provide some control over 
known covariates of QSTs (e.g. sex and age), we attempted 
to match controls to recruited participants with PF on the 
basis of sex and age. Reporting of this study follows the 
STROBE statement: guidelines for reporting observational 
studies [21]. Ethical approval was granted by the Medical 
Research Ethics Committee of the University of Queens-
land, and all participants provided written informed 
consent prior to participation. The study was conducted 
in accordance with the Declaration of Helsinki [22].
2.2   Setting
The study was conducted at the University of Queensland, 
Brisbane, Australia. Participants were recruited from June 
1st 2017 to July 21st 2017 through public advertisements in 
the local community and social media (Facebook). Poten-
tially eligible participants who had completed an online 
questionnaire then underwent a telephone interview to 
further determine eligibility, and those who matched the 
criteria were invited to attend a physical examination 
at the University of Queensland during which eligibility 
was confirmed with clinical diagnostic tests. The assessor 
responsible for confirming inclusion, including perform-
ing ultrasound measurements, and data collection was a 
registered physiotherapist with 6  years of experience in 
treating patients with musculoskeletal disorders.
2.3   Participants
The inclusion criteria of the individuals with plantar fas-
ciopathy were: (i) plantar heel pain for at least 3  months 
before enrolment; (ii) average heel pain intensity of ≥2 on 
an 11-point numerical rating scale (NRS, 0 is no pain, 10 is 
worst pain imaginable) during the previous week [23]; (iii) 
thickness of the plantar fascia of 4.0 mm or greater as meas-
ured by ultrasonography [24] and; (iv) pain on palpation 
of the medial calcaneal tubercle or the proximal plantar 
fascia. The exclusion criteria were: (i) below 18 years of age; 
(ii) history of inflammatory systemic diseases [23]; (iii) prior 
heel surgery; (iv) pregnancy; (v) pain medication 24 h prior 
to examination; (vi) corticosteroid injection for plantar fas-
ciopathy within the previous 6 months and; (vii) other mus-
culoskeletal injuries for which treatment was sought within 
the previous 6 months. Controls were selected on the same 
criteria with the exception that they were not to have any 
history of heel pain or other lower limb pain.
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2.4   Outcomes
The study outcomes included: (i) PPT measured in kPa 
of the two groups (plantar fasciopathy and controls); 
(ii) CPM measured in kPa. The CPM effect was defined as 
the change in pressure pain threshold (PPT) from before 
cold water immersion of the hand to when PPT was re-
tested during immersion. (iii) cold pain threshold (CPT) 
measured in °C; (iv) heat pain threshold (HPT) measured 
in °C; (v) rating of perceived pain on pain thresholds 
measured on an 11-point NRS and; (vi) water temperature 
during cold water immersion measured in °C. All pain 
threshold tests were measured locally at the plantar heel 
(most tender point in patients and antero-medially in con-
trols) and at a distant site of the lateral elbow.
2.5   Pressure pain thresholds
Pressure pain thresholds were assessed using a hand-held 
algometer (Somedic, Ho﻿̈rby, Sweden) with a 1 cm2 probe. 
PPT testing at the plantar surface of the heel in patients 
with PF has been found to have a good intra-rater reli-
ability (ICC = 0.75–0.92) [15]. The probe was placed per-
pendicular to the skin and pressure was applied at a rate 
of 30 kPa/s. The participants were instructed to push the 
button of a hand-held switch when they first felt the sen-
sation of pressure change to a sensation of pain and the 
test was terminated. A maximum pressure of 1,200 kPa 
was applied. If any participant reached this level of pres-
sure the assessor would terminate the test. Due to a pos-
sible ceiling effect of the pressure pain threshold at the 
plantar aspect of the heel in the control group, as found 
during preliminary testing, the soleus muscle was chosen 
as an additional test site in this group.
2.6   Conditioned pain modulation
Investigating CPM is used to explore the efficacy of the 
endogenous pain inhibition [25]. The test stimulus was 
PPT and the conditioning stimulus was immersion of the 
hand into cold water. After the PPT measurement under 
the heel was assessed as described above, the contralat-
eral hand to the test side was immersed in circulating 
cold water with a starting temperature of 12–14 °C [6, 18, 
26]. After 30  s of immersion, the participant was asked 
to rate the perceived pain in the hand on an 11-point NRS 
(ranging from 0 which was no pain to 10 which was the 
worst pain imaginable). The water temperature was either 
increased or decreased by adding warm water or ice until 
the participant rated their hand pain within a range of 4–6 
out of 10 and then the PPT testing was performed at the 
plantar surface of the heel. The participant was instructed 
to rate the hand pain again if they felt it had changed 
and the temperature would be adjusted to keep them 
within the range of 4–6 out of 10 throughout the immer-
sion of the hand in the cold water. After the PPT test, the 
hand was removed from the water. As soon as possible (no 
later than 30 s after removal of the hand out of the cold 
water), an additional PPT measurement was performed. 
In the control group, PPTs of the soleus were tested imme-
diately after the hand was removed from the water and 
before the PPTs under the heel were re-tested. In cases 
where control participants did not experience pain before 
a pressure under the heel of 1,200 kPa was reached, the 
before and after immersion PPT measurements of the 
soleus would be used to measure CPM. The PPTs were 
assessed over the soleus muscle at 40% of the length from 
the medial malleolus to the medial knee joint line.
2.7   Thermal pain thresholds
The cold pain thresholds were measured using the Ther-
motest system (Somedic, Farsta, Sweden) [7]. The ther-
mode was placed on the skin at the test sites and from 
a temperature of 32 °C the temperature of the thermode 
decreased at a rate of 1 °C/s. The participant was instructed 
to push the button of a hand-held switch when they first 
experienced the onset of pain and the test was terminated. 
If the participant did not experience pain the test was ter-
minated when the minimum cut-off temperature of 5 °C 
was reached. The heat pain thresholds were investigated 
using the same Thermosystem as with CPT and used the 
same starting temperature of 32 °C. The temperature of the 
thermode increased until participants first experienced 
pain or when the maximum cut-off temperature of 50 °C 
was reached.
2.8   Pain area and distribution
To assess the area and distribution of pain, plantar fascio-
pathy participants completed pain drawings on a detailed 
body chart of the foot soles as well as the whole body front 
and back views on a personal computer tablet (Samsung 
Galaxy note 10.1, 2014 Edition) using the Navigate Pain 
app (Aalborg University, Denmark) [27, 28]. All pain draw-
ings of the feet were visually assessed by an experienced 
assessor (SAB) for the presence of symmetrical pain. Sym-
metrical pain drawings are defined as mirrored images of 
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the left and right foot and to a high extent cover the same 
anatomical areas. The total area drawn, expressed as the 
total number of pixels, were automatically extracted. A 
visual assessment of each pain drawing was performed 
to determine the locations of pain and recorded as local 
versus widespread (i.e. pain spreading beyond the plantar 
heel region) as well as unilateral versus bilateral pain. 
Further, the total number of independent non-contiguous 
pain sites was also recorded. All drawings were exported 
offline to create an overlay image detailing plantar fascio-
pathy pain distribution on the foot soles.
2.9   Procedure
After eligibility had been confirmed the plantar fasciopa-
thy group completed the Foot Function Index question-
naire (FFI) to assess the severity of the condition. The FFI 
is a self-report questionnaire, ranging from 0 (no pain, 
disability or activity limitation) to 100 (worst pain and 
disability), that assesses multiple dimensions of foot 
function [29].
For participants who presented with bilateral plantar 
fasciopathy, the self-reported most affected side was the 
test side and for the controls the test side was randomised 
by the flip of a coin. By way of palpation the most tender 
spot at the plantar heel was used for the test site while 
the antero-medial aspect of the plantar heel was used as 
the test site for controls. The ipsilateral elbow was used 
as the remote test site in both groups. When testing was 
performed on the elbow (measured first), the participant 
lay supine on the examination table and then lay prone 
when testing was performed at the plantar heel (measured 
second). All tests were repeated three times with 30 s of 
rest in between and mean values were used for all analy-
ses. After each test, the participants were asked to rate the 
level of perceived pain at its first onset on an 11-point NRS 
[30].
2.10   Sample size
As this was a pilot study, no formal sample size calcula-
tion was performed [31, 32]. We aimed to include 20 par-
ticipants in each group.
2.11   Statistical methods
Data normality was assessed using Q-Q plots. Descrip-
tive statistics were reported using mean and standard 
deviation (SD) or median and interquartile range (IQR), 
frequency counts (%) and effect sizes (d). Interpretation 
of effect sizes ranged from very small (d = 0.01) to huge 
(d = 2.0) [30]. Due to the nature of a pilot study, no hypoth-
esis testing was performed [32]. Between-group differ-
ences were reported as mean differences (95% confidence 
intervals (CI)) and were adjusted for sex to account for 
potential sex influences [17].
A post-hoc evaluation of differences in total pain area 
between heel pain participants who had local versus wide-
spread pain was analysed with Mann-Whitney U-tests 
(with 95% confidence limit). Associations between pain 
area and mean pain during the past week and symptom 
duration were investigated using Spearman’s rank cor-
relation coefficient and associations between mean pain 
during the past week and PPT under the heel and CPM 
effect were explored using Pearson’s correlation coeffi-
cient. STATA ver. 14 was used for all analyses.
3   Results
The time-frame of the study limited recruitment and an 
eligible sample of 16 in the PF group and 11 in the control 
group was achieved at the end of recruitment. Of the 
366 individuals who completed the online questionnaire 
advertised on Facebook, 106 were eligible for telephone 
screening. Of these, 33 individuals were eligible for clini-
cal examination. One was ineligible due to a plantar 
fascia thickness <4  mm as determined by ultrasonog-
raphy, and 16 did not attend their appointment. This 
resulted in 16 individuals with PF being included (see 
flow chart in supplementary material). Twelve potential 
participants of the control group either responded to an 
online questionnaire or contacted the assessor directly. 
One had musculoskeletal pain and was excluded on that 
basis which resulted in the inclusion of 11 pain-free par-
ticipants in the control group. Clinical and demographic 
characteristics were similar in the groups in terms of age, 
height and weekly sports participation (p > 0.05), but BMI 
was higher in the PF group compared with the control 
group (mean difference: 6.6 kg/m2, 95% CI: 2.7–10.5, 
p = 0.002) and the proportion of females was higher in the 
PF group (12/16 vs. 6/11) (Table 1). Two participants had 
taken days off work (1 and 5 days) due to their heel pain. 
One participant in the control group reached 1,200 kPa 
during all PPT tests under the heel. For this participant 
the PPT measures of the soleus were used in the analysis 
of CPM effect as they were repeated from pre to post cold 
water immersion.
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3.1   Outcomes
The PF group demonstrated lower PPTs at the plantar heel 
with a very large effect size (d = 1.8) and on the elbow with 
a medium effect size (d = 0.7) (Table 2, Figs. 1 and 2). There 
was no between-group difference for CPM (mean differ-
ence = − 21.5 kPa, 95% CI: −119.6 to 76.7) (Table 2, Fig. 1). 
The median relative change in PPT under the heel during 
immersion expressed as percentage of pre-immersion PPT 
was 20% in the PF group and 16% in the control group. 
Small mean differences were seen for the thermal thresh-
olds with effect sizes ranging from very small to medium 
(CPT d = 0.1 to d = 0.5; HPT d = 0.2 to d = 0.5). Not all partici-
pants experienced an onset of pain within the pre-deter-
mined temperature limits (i.e. 5–50 °C). In the PF group, 
nine participants did not reach the CPT on the elbow and 
five did not reach it under the heel, and one did not reach 
the HPT on the elbow and twelve did not reach the HPT 
Table 1: participant characteristics (mean (SD) or count).
  PF group (n = 16)  Control group (n = 11)
Sex, females (%)   12 (75%)  6 (56%)
Age (years)   47.0 (9.4)  45.7 (12.8)
Height (cm)   169.9 (10.1)  172.0 (6.4)
Mass (kg)   84.6 (18.3)  67.5 (9.9)
BMI (kg/m2)   29.3 (6.0)  22.7 (2.5)
Weekly sports participation (minutes)   247.5 (183.8)  283.2 (225.3)
Symptom durationa (months)   8.5 (6–14.5)  N/A
Pain during past week (0–10 NRS)   4.6 (1.4)  N/A
FFI (/100)   74.8 (29.5)  N/A
Sought treatment (%)   13 (81%)  N/A
Bilateral pf (%)   7 (44%)  N/A
pf = plantar fasciopathy; BMI = body mass index; FFI = foot function index; NRS = numerical rating scale.
amedian (inter-quartile range).
Table 2: Results of quantitative sensory testing.
  PF group 
(n = 16)
  Control group 
(n = 11)
  Mean difference adjusted 




 CPM effect (kPa)   93.0 (121.7)   103.6 (114.8)   −21.5 (−119.6 to 76.7)   0.1
 PPT before immersion (kPa)   380.0 (225.9)   810.9 (246.6)   −406.6 (−598.6 to −214.6)a   1.8
 Pain rating (NRS)   3.7 (1.7)   1.1 (0.5)   2.6 (1.5–3.6)a   2.1
 CPT (°C)   9.0 (3.6)   8.5 (5.0)   0.7 (−2.9 to 4.2)   0.1
 Pain rating (NRS)   1.9 (2.0)   0.5 (0.8)   1.3 (−0.1 to 2.6)   0.9
 HPT (°C)   49.3 (2.0)   49.6 (0.6)   −0.2 (−1.5 to 1.1)   0.2
 Pain rating (NRS)   1.4 (2.2)   0.9 (1.3)   0.3 (−1.3 to 1.9)   0.3
 Pain rating of PPT during immersion (NRS)  4.0 (1.5)   1.3 (0.8)   2.7 (1.6–3.8)a   2.3
 PPT after immersion (NRS)   428.9 (185.5)   827.3 (243.6)   −379.3 (−553.2 to −205.4)   1.8
 Pain rating of PPT after immersion (NRS)   4.1 (1.8)   1.4 (0.9)   2.6 (1.4–3.8)a   1.9
Elbow
 PPT (kPa)   376.4 (203.8)   508.4 (200.5)   −109.3 (−274.3 to 55.7)   0.7
 Pain rating (NRS)   3.1 (1.7)   1.6 (0.8)   1.5 (0.3–2.7)a   1.1
 CPT (°C)   8.0 (5.1)   6.0 (2.7)   2.2 (−1.4 to 5.8)   0.5
 Pain rating (NRS)   0.9 (1.3)   0.2 (0.4)   0.6 (−0.3 to 1.5)   0.7
 HPT (°C)   46.0 (2.4)   47.3 (2.4)   −0.9 (−2.8 to 1.0)   0.5
 Pain rating (NRS)   4.3 (2.3)   1.7 (0.8)   2.6 (1.0–4.1)a   1.5
Data presented as mean (SD).
Mean differences adjusted for sex.
CPM = conditioned pain modulation; PPT = pressure pain threshold; CPT = cold pain threshold; HPT = heat pain threshold; NRS = numerical 
rating scale.
aStatistical significance.
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under the heel. In the control group, eight participants did 
not reach the CPT on the elbow and six did not reach it 
under the heel, and all reached the HPT on the elbow but 
five did not reach the HPT under the heel. Perceived pain 
on pain onset was higher for the PF group compared to 
the control group during all PPT measurements and effect 


























Fig. 1: Individual participant data of pressure pain thresholds 
under the heel before and during immersion of the hand to test the 
conditioned pain modulation. Means and standard deviations are 






















Fig. 2: Individual participant data of pressure pain thresholds on 






























Fig. 3: Individual participant data of perceived pain under the heel 
on pain onset during pressure pain thresholds under the heel before 
and during immersion of the hand. Means and standard deviations 






























Fig. 4: Individual participant data of pain ratings on pain onset 
during pressure pain thresholds on the lateral elbow. Means and 
standard deviations are shown as dots with error bars.
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in perceived pain on thermal pain thresholds were 
observed, however, the effect sizes ranged from small to 
very large (Table 2). The water temperature at the time of 
PPT testing during cold water immersion was on average 
14.3 (±3.0) °C in the PF group and 12.1 (±2.9) °C in the 
control group (mean difference: 2.2 °C, 95% CI: −0.3 to 4.7, 
d = 0.8). We found no association between pain during the 
past week and PPT under the heel (r =  −0.327, p = 0.216) or 
CPM (r = 0.208, p = 0.438).
3.2   Pain drawings
A superimposed overlay of the original pain drawings 
from the test side drawings is presented in Fig. 5. Six out 
of seven individuals with bilateral pain presented with a 
symmetrical plantar pain distribution. Half of the indi-
viduals showed widespread pain which extended beyond 
the plantar heel. In total, three out of nine with unilateral 
pain and five out of seven of those with bilateral plantar 
fasciopathy reported pain on the anterior and/or posterior 
lower limb body charts (Fig. 6).
The total area of plantar heel pain, but not pain sites, 
was greater for individuals presenting with widespread 












Fig. 5: An overlay made by superimposing the 16 original pain 
drawings from individuals with PF. The darker areas indicate a higher 





















Fig. 6: An overlay made by superimposing the 8 original pain drawings from individuals with PF who drew pain on the lower limb body 
charts. The darker areas indicate a higher degree of overlap between drawings and the common pain locations.
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localised heel pain ((mean rank = 5.15) U = 59.00, z = 2.836, 
p = 0.005). The total area of plantar heel pain was not 
related to the mean pain or the duration of reported pain 
(p = 0.351).
3.3   Adverse events
No adverse events were observed.
4   Discussion
4.1   Key results
This was the first study to investigate the presence of 
altered pain processing using thermal pain thresholds 
and a CPM paradigm in individuals with plantar fascio-
pathy. Despite the study being a pilot with small numbers, 
the findings indicate that it is unlikely that endogenous 
inhibitory pain modulation as tested with our CPM pro-
tocol is different in individuals with plantar fasciopathy 
when compared to pain-free controls. Individuals with 
plantar fasciopathy demonstrated localised mechanical 
hyperalgesia at the plantar heel and rated pain higher at 
local and remote test sites compared with the controls. 
Altogether, these findings warrant further research in 
pain processing in plantar fasciopathy to confirm differ-
ences between individuals with plantar fasciopathy and 
pain-free controls.
4.2   Interpretation
Two recent studies of pressure pain hypersensitivity found 
widespread pain in individuals with unilateral PF com-
pared with healthy individuals [13, 14]. However, individu-
als with plantar fasciopathy reported higher pain ratings 
than those of the present study (5.7 and 6.3 NRS vs. 4.6 NRS, 
respectively). In one of the studies [13], individuals with 
plantar fasciopathy reported considerably longer symptom 
durations to that of the present study (18.4 vs. 8.5 months, 
respectively). Indeed, higher pain ratings and longer 
symptom duration may reflect greater condition severity. 
Thus, it is a possibility that condition severity of the indi-
viduals with plantar fasciopathy in the present study were 
less and this may have contributed to the lack of a clear 
indication of widespread mechanical hypersensitivity. 
The control group did show slightly higher pressure pain 
thresholds (PPTs) on the elbow than the PF group (d = 0.7) 
but also seemingly higher than those of pain-free controls 
in other similar studies [33–35]. Therefore, any potential 
difference between individuals with plantar fasciopathy 
and pain-free controls at the remote site in the present 
study could be the result of unusually high PPTs among 
controls rather than low PPTs in the PF group. A lack of a 
between-group difference is in line with findings by Plins-
inga et al. [33] where no remote pressure pain hyperalgesia 
was found in Achilles or patellar tendinopathy. Together 
with the results of the present study, there is now conflict-
ing evidence regarding altered pain processing in both 
Achilles tendinopathy and plantar fasciopathy [33]. Future 
larger-scale studies should include additional quantitative 
sensory tests to either confirm or dismiss the role of altered 
pain processing in persistent plantar fasciopathy.
If reduced endogenous inhibition was present, it 
could be assumed that the PF group would have had lower 
CPM, defined as a smaller increase in PPT during the cold 
water immersion, than the controls as seen in Achilles 
tendinopathy by Tompra et al. [6], still, it appears unlikely 
that there is a difference between individuals with PF and 
controls (d = 0.1). Based on our findings and using a two-
sided 5% significance level and a power of 80%, a sample 
size of 3,914 participants would be required to find a sig-
nificant difference. This implies that when using our CPM 
procedure, it is highly unlikely that further research into 
CPM of plantar fasciopathy is warranted.
We found lower PPTs under the heel in the PF group 
compared with the control group which is contrary to the 
findings of Saban et al. [15]. In the present study, PPT was 
assessed over the most tender location in contrast to the 
study by Saban et al. where PPTs were assessed over mul-
tiple standardised sections of the heel. It can be argued 
that using the most sensitive area for PPT assessments 
would give the most precise reflection of pain sensitiv-
ity rather than standardised sections of the plantar heel 
should the measure be adopted in the clinic.
Pain ratings on all pain thresholds were higher among 
individuals with plantar fasciopathy which indicates that 
their perception of pain is more intense than that of pain-
free individuals. Similar findings have been seen in carpal 
tunnel syndrome where no altered pain processing was 
found when patients were compared to matched controls 
but ratings of pain were higher at remote sites [35]. There 
might be other factors that contribute to these higher pain 
ratings, for example, kinesiophobia, anxiety, and pain 
catastrophizing that can influence pain perception and 
have been found to be higher in individuals with plantar 
fasciopathy compared with healthy controls [36]. We did 
not record these pain related measures and recommend 
future research to include them.
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Patients with plantar fasciopathy indicated the area 
and location of their pain covered a much larger area than 
clinical dogma and text-book presentations. The text-book 
presentation is on the antero-medial aspect of the calca-
neus, whereas in our study pain extended to cover the 
entire plantar heel region and half of the proximal arch 
of the foot [37]. This fits with the idea that the association 
between the perception of pain and tissue integrity is less 
clear [38]. Another possibility might be that the plantar 
fascia is not the only structure contributing to the pain 
experience.
Six out of seven individuals with bilateral pain had 
symmetrical pain patterns, that is pain was expressed in 
the same locations of both feet. Similar findings have been 
seen in other chronic pain conditions such as patellofem-
oral pain and rheumatoid arthritis [20, 39]. It is unclear 
whether the severity of a chronic condition is associated 
with symmetrical or asymmetrical patterns [39], however, 
bilateral pain is also associated with poorer prognosis and 
longer symptom duration compared with unilateral pain 
which should be considered in clinical practice [19, 40].
4.3   Limitations
This study is not without limitations. First, despite adver-
tisement on social media and handing out flyers, we were 
not able to recruit the planned sample size within the time 
frame of the study. Further, 16/33 patients with plantar 
fasciopathy cancelled their appointment which should be 
accounted for in a future larger scale study. Second, the 
thermosystem did not allow for temperatures lower than 
5 °C or higher than 50 °C and several participants of both 
groups did not reach their CPT or HPT within these tem-
peratures. Third, the assessor was not blinded to group 
allocation, largely due to resource implications and PPT 
being applied to the most tender spot at the plantar the 
heel in the PF group. Fourth, as we used a target pain 
rating rather than a target water temperature, the immer-
sion times were not the same between participants which 
could potentially have influenced the stimulus received, 
however, this applied to both groups and is not likely to 
have affected the between-group comparisons.
4.4   Generalisability
The participants of the PF group are comparable to those 
of previous studies in terms of age and had a higher BMI 
compared with the controls. A high BMI has been found to 
be associated with plantar fasciopathy [41].
4.5   Conclusions
Although the recent findings of widespread hyperalgesia 
in plantar fasciopathy support altered pain processing as 
a feature, we were unable to substantiate this in our study. 
We did not find that individuals with plantar fasciopathy 
had reduced endogenous inhibition compared to healthy 
controls and could not draw firm conclusions of lower 
remote pain thresholds. We did observe higher perceived 
pain on pain threshold and a pain area that extended 
beyond the antero-medial aspect of the plantar heel, 
which in conjunction with recent findings of widespread 
hyperalgesia provide rationale for exploring altered pain 
processing in a larger-scale study.
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